Perioperative beta-blockers reduced arrhythmias but did not reduce mortality in cardiac (OR 0.55; 95% CI 0.17-1.83) or noncardiac surgery (OR 0.78; 95% CI 0.33-1.87).
Meta-Analysis
Do perioperative beta-blockers reduce mortality and morbidity in patients undergoing cardiac and noncardiac surgery?
Perioperative beta-blockers reduce arrhythmias and myocardial ischemia but do not improve hard clinical outcomes like mortality or myocardial infarction.
Odds Ratio: 0.55 (95% CI 0.17–1.83)
BACKGROUND: Perioperative beta-blockers are suggested to reduce cardiovascular mortality, myocardial-ischemia/infarction, and supraventricular arrhythmias after surgery. We reviewed the evidence regarding the effectiveness of perioperative beta-blockers for improving patient outcomes after cardiac and noncardiac surgery. METHODS: Eleven large databases were searched from the time of their inception until October 2005. Various online-resources were consulted for the identification of unpublished trials and conference abstracts. We included randomized, controlled trials comparing perioperative beta-blockers with either placebo or the standard-of-care. Of the 3680 retrieved titles, 69 met inclusion criteria for analysis. Odds ratios (OR) assuming random effects were computed in the absence of significant clinical heterogeneity. RESULTS: Beta-blockers reduced the frequency of ventricular tachyarrhythmias OR (cardiac surgery): 0.28, 95% CI 0.13-0.57; OR (noncardiac surgery): 0.56, 95% CI 0.21-1.45, atrial fibrillation/flutter OR (cardiac surgery): 0.37, 95% CI 0.28-0.48, other supraventricular arrhythmias OR (cardiac surgery): 0.25, 95% CI 0.18-0.35; OR (noncardiac surgery): 0.43, 95% CI 0.14-1.37, and myocardial ischemia OR (cardiac surgery): 0.49, 95% CI 0.17-1.4; OR (noncardiac surgery): 0.38, 95% CI 0.21-0.69. Length of hospitalization was not reduced weighted mean difference (cardiac surgery): -0.35 days, 95% CI -0.77-0.07; weighted mean difference (noncardiac surgery): -5.59 days, 95% CI -12.22-1.04 and, in contrast to previous reports, beta-blockers did not reduce mortality OR (cardiac surgery): 0.55, 95% CI 0.17-1.83; OR (noncardiac surgery): 0.78, 95% CI 0.33-1.87, and they had no influence on the occurrence of perioperative myocardial infarction OR (cardiac surgery): 0.89, 95% CI 0.53-1.5; OR (noncardiac surgery): 0.59; 0.25-1.39. CONCLUSIONS: Beta-blockers reduced perioperative arrhythmias and myocardial ischemia, but they had no effect on myocardial infarction, mortality, or length of hospitalization.
Wiesbauer et al. (Wed,) conducted a meta-analysis in cardiac and noncardiac surgery. Perioperative beta-blockers vs. placebo or standard-of-care was evaluated on mortality (cardiac surgery) (OR 0.55, 95% CI 0.17-1.83). Perioperative beta-blockers reduced arrhythmias but did not reduce mortality in cardiac (OR 0.55; 95% CI 0.17-1.83) or noncardiac surgery (OR 0.78; 95% CI 0.33-1.87).